Screener Companies About
NYSE:HWM
Industrials Aerospace & Defense

Howmet Aerospace Inc.

A premier producer of critical aircraft structural parts and engine components driving the expansion of global air travel.

■ Key Metrics

Revenue
$8.25B
Net Income
$1.51B
Gross Profit
$2.82B
Operating Cash Flow
$1.88B
Total Assets
$11.18B
Shareholders' Equity
$5.35B
Long-Term Debt
$2.86B
Cash & Equiv
$742.0M

⚖ Investment Thesis

Bull Case

Howmet benefits from a secular tailwind as global aviation demand rebounds and fleet modernization accelerates toward more fuel-efficient aircraft. The company's dominant market position and expanding mix of high-margin engine components provide a resilient earnings profile with strong potential for organic growth.

Bear Case

Investors should be wary of the heavy capital expenditure requirement of $453M, which can strain cash reserves if demand slows unexpectedly. High debt levels relative to equity, including $2.86B in long-term debt, could limit financial flexibility during periods of rising interest rates or economic recession.

◉ About Howmet Aerospace Inc.

Howmet Aerospace Inc. is a leading global manufacturer of aerospace components and products, serving commercial airlines, defense contractors, and industrial markets with high-performance aluminum and titanium alloys.

⚙ Analysis

Management Discussion

The company demonstrated robust financial growth with revenue expanding from $5.66B in 2022 to $8.25B in 2025, driven by strong aircraft deliveries and pricing power. Net income surged alongside top-line growth, rising from $469M to $1.51B over the same period, while free cash flow generation of $1.88B highlights operational efficiency.

Industry Overview

The aerospace manufacturing industry is characterized by high barriers to entry, stringent regulatory standards, and a slow but steady growth trajectory linked to global GDP and passenger traffic recovery. Consolidation is common as leading players acquire smaller suppliers to secure supply chain control and achieve economies of scale.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric2022202320242025
Revenue$5.66B$6.64B$7.43B$8.25B
Cost of Revenue$4.10B$4.77B$5.12B$5.43B
Gross Profit$1.56B$1.87B$2.31B$2.82B
Operating Expenses$641.0M$664.0M$678.0M$774.0M
Operating Income$919.0M$1.20B$1.63B$2.05B
R&D$32.0M$36.0M$33.0M$37.0M
G&A$288.0M$333.0M$347.0M$370.0M
Stock-Based Comp$54.0M$50.0M$63.0M$73.0M
D&A$265.0M$272.0M$277.0M$283.0M
Depreciation$227.0M$236.0M$243.0M$248.0M
Amortization$36.0M$35.0M$33.0M$32.0M
Other OpEx$321.0M$295.0M$298.0M$367.0M
Non-Operating Income$-313.0M$-228.0M$-250.0M$-206.0M
Interest Expense$229.0M$218.0M——
Interest Income——$20.0M$20.0M
Pre-Tax Income$606.0M$975.0M$1.38B$1.84B
Income Tax$137.0M$210.0M$228.0M$332.0M
Continuing Ops$469.0M$765.0M$1.16B$1.51B
Discontinued Ops$0$0$0$0
Net Income$469.0M$765.0M$1.16B$1.51B
Minority Interest$0$0$0$0
Net to Common$469.0M$765.0M$1.16B$1.51B
Metric2022202320242025
Current Assets$3.14B$3.32B$3.36B$3.78B
Cash & Equivalents$791.0M$610.0M$564.0M$742.0M
Accounts Receivable$506.0M$675.0M$689.0M$779.0M
Inventory$1.61B$1.76B$1.84B$1.85B
Prepaid Expenses$206.0M$249.0M$249.0M$392.0M
Other Current Assets$31.0M$17.0M$20.0M$17.0M
Long-Term Assets$7.11B$7.11B$7.16B$7.40B
PP&E (Net)$2.33B$2.33B$2.39B$2.59B
Intangibles$521.0M$505.0M$475.0M$457.0M
Goodwill$4.01B$4.04B$4.01B$4.02B
Operating Leases$111.0M$128.0M$155.0M$162.0M
Other LT Assets$135.0M$116.0M$131.0M$166.0M
Total Assets$10.26B$10.43B$10.52B$11.18B
Current Liabilities$1.48B$1.78B$1.55B$1.77B
Accounts Payable$962.0M$982.0M$948.0M$845.0M
Current Debt$0$206.0M$6.0M$191.0M
Current Leases$32.0M$32.0M$37.0M$42.0M
Deferred Revenue———$147.0M
Other Current Liab$488.0M$564.0M$558.0M$546.0M
Long-Term Liabilities$5.17B$4.61B$4.42B$4.05B
Long-Term Debt$4.16B$3.50B$3.31B$2.86B
LT Operating Leases$83.0M$97.0M$119.0M$121.0M
Other LT Liab$927.0M$1.01B$988.0M$969.0M
Total Liabilities$6.65B$6.39B$5.96B$5.83B
Shareholders' Equity$3.60B$4.04B$4.55B$5.35B
Paid-In Capital$3.95B$3.68B$3.21B$2.53B
Retained Earnings$1.03B$1.72B$2.77B$4.09B
AOCI$-1.84B$-1.83B$-1.88B$-1.67B
Total L&E$10.26B$10.43B$10.52B$11.18B
Metric2022202320242025
Net Income (CFO)$469.0M$765.0M$1.16B$1.51B
Non-Cash Adjustments$-333.0M$-187.0M$49.0M$108.0M
Working Capital Changes$597.0M$323.0M$94.0M$268.0M
Cash from Operations$733.0M$901.0M$1.30B$1.88B
Capital Expenditures$193.0M$219.0M$321.0M$453.0M
Cash from Investing$-135.0M$-215.0M$-316.0M$-438.0M
Debt Issuances$0$400.0M$500.0M$500.0M
Debt Repayments$69.0M$876.0M$865.0M$765.0M
Share Buybacks$400.0M$250.0M$500.0M$700.0M
Cash from Financing$-526.0M$-868.0M$-1.03B$-1.27B
FX Effect$-2.0M$0$-1.0M$1.0M
Net Change in Cash$70.0M$-182.0M$-45.0M$178.0M
Beginning Cash$722.0M$792.0M$610.0M$565.0M
Ending Cash$792.0M$610.0M$565.0M$743.0M

Frequently Asked Questions

How does Howmet Aerospace Inc. make money?

Commercial Aircraft Systems providing fuselage skins, frames, and floor panels; Engine Components manufacturing fan blades, compressor disks, and casings; Industrial Products offering specialized extrusions and heat exchangers for HVAC and energy sectors; Defense & Security supplying secure communication systems and ruggedized electronics.

What are the main risks for HWM?

Cyclical dependency on global airline capital expenditure budgets and aircraft delivery schedules which can fluctuate based on fuel prices and economic downturns; Exposure to volatile raw material costs for aluminum and titanium impacting gross margins; Geopolitical tensions affecting supply chains in key manufacturing regions like China and Europe.

What is HWM's competitive advantage?

Unmatched vertical integration allowing precise control over raw material supply chains and production costs; Proprietary aerospace-grade aluminum and titanium metallurgical expertise; Decades of established relationships with major OEMs like Boeing, Airbus, and GE Aviation ensuring long-term contract stability.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.